Русский

Pharmaceutical Industry Information Portal

HomeTagsDrug patent

All posts by tag

drug patent

World Pharma News

Novartis loses over $2.7 billion in patent appeal of multiple sclerosis drug

Techno -
A U.S. appeals court on Tuesday ruled that a patent related to Swiss drugmaker Novartis AG's blockbuster multiple sclerosis drug Gilenya was invalid, potentially...
Manufacturers News

The new direct acting anticoagulant in the anticovid portfolio of Promomed Group

Techno -
Promomed Group received marketing authorization certificate for a medicinal product with nadroparin calcium as active ingredient. Nadroparin is a low molecular weight heparin. It...
Pharma marketing analytics

Top biopharma companies could be affected by Brazilian drug patent suspension

Techno -
GlaxoSmithKline will be the most affected, as it represents 26% of the potentially impacted drugs. This is followed by Novartis at 14%, Sanofi at 11%, and both Pfizer and Bayer with 8%.
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories